ABSTRACT Biliary tract cancers (BTCs) are aggressive malignancies associated with a poor prognosis. Although molecular profiling is recommended to guide therapeutic decision‐making, real‐practice data on the prevalence and prognostic significance of genomic alterations in European BTC cohorts remain limited.
Jorine Arnouts +14 more
wiley +1 more source
Changing epidemiology and etiology of hepatocellular carcinoma in Europe: implications for clinical practice and health policy. [PDF]
Scheiner B +9 more
europepmc +1 more source
ABSTRACT Tibolone, a synthetic steroid with estrogenic, progestogenic, and androgenic activity, is widely prescribed for menopausal symptoms, but its association with hepatocellular carcinoma (HCC) remains unclear. Using data from 117,271 women aged ≥ 45 years in the Korean National Health Insurance Service–Health Screening Cohort, we evaluated ...
Jimin Lee +9 more
wiley +1 more source
Radiation segmentectomy for hepatocellular carcinoma: redefining the limits of curative-intent therapy. [PDF]
Bozzi E +11 more
europepmc +1 more source
Physical Activity and Risk of Liver Cancer: A Competing Risk Analysis
ABSTRACT Physical activity is associated with lower risk of liver cancer, but obtaining an unbiased estimate of the causal effect is challenging due to the competing risk of death due to any other cause. We performed a causal competing risk analysis to estimate the total effect of physical activity on risk of liver cancer in the presence of competing ...
Frances E. M. Albers +9 more
wiley +1 more source
Response to: "Considerations on the Histologic Definition and Clinical Translation of Burnt-Out MASLD in Resected HCC". [PDF]
Watanabe Y +3 more
europepmc +1 more source
Interpretable prediction of macrotrabecular-massive HCC and recurrence-free survival by integrating MRI LI-RADS features with deep learning habitat radiomics. [PDF]
Zhang M +11 more
europepmc +1 more source
Combined hepatocellular cholangiocarcinoma: A rare hepatic malignancy exhibiting concurrent imaging features of hepatocellular carcinoma and intrahepatic cholangiocarcinoma. [PDF]
Qian XJ, Girgis S, Wilson MP, Low G.
europepmc +1 more source

